References
- Knaus W A, Draper E A, Wagner JE. Apache II: a severity of disease classification system. Crit Care Med 1985; 13: 818–829
- Henderson L W, Quellhorst E A, Baldamus C A, Lysaght MJ. Hemofiltration. Springer, New York 1986
- Gattinoni L, Agostini A, Pesenti A, Pelizzola A, Rossi G, Langer M, Vesconti S, Uziel L, Longini F, Fox U, Kolobov T. Treatment of acute respiratory failure with low frequency positive pressure ventilation and extracorporeal removal of COs. Lancet 1980; 2: 292–295
- Klotz U. Individualisierung der Medikamentendosierung durch Arzneimittelmessungen im Plasma und Anwendung pharmakik-inetischer Prinzipien. J Clin Chem Biochem 1983; 21: 649–658
- Sheiner L B, Beal SL. Bayesian individualization of pharmacokinetics: simple implementation and comparison with nonbaye-sian methods. J Pharm Sci 1982; 71: 1344–1348
- Zaske D E, Irvine P, Strand L M, Strate R G, Cipolle R J, Rotschafer J. Wide interpatient variations in gentamycin dose requirements for geriatric patients. J Am Med Assoc 1982; 248: 3122–3126
- Kroh U. Pharmacokinetics in extracorporeal circulation. Neonatal and Adult Respiratory Failure. Mechanisms and Treatments, JP Gille. Elsevier, Paris 1989; 197–206
- Kroh U, Hofmann W, Dehne M, El Abed K, Lennartz H. Dosisanpassung von Pharmaka wahrend kontinuierlicher Hamofiltration. Anaesthesist 1989; 38: 225–232
- Kroh U F, Dehne M, El Abed K, Feußner K D, Hofmann W, Lennartz H. Drug dosage during continuous hemofiUration: pharmacokinetics and practical implications. Contrib Nephrol 1991; 93: 56–59
- Elebute A N, Stoner HB. The grading of sepsis. Br J Surg 1983; 70: 29–31
- Bennett W M, Aronoff G R, Morrison G, Golper T A, Pulliam J, Wolfson M, Singer I. Drug prescribing in renal failure: dosing guidelines for adults. Am J Kidney Dis 1983; 3: 155–193
- Golper T A, Wedel S K, Kaplan A A, Saad A M, Donta S T, Paganini EP. Drug removal during continuous arteriovenous nemo-filtration: theory and clinical observation. Int J Artif Organs 1985; 8: 307–312
- Heinzel G. Salient points of various programs: TOPFIT. Pharmacokinetics During Drug Development: Data Analysis and Evaluation Techniques, G Bozler, JM Van Rossum. Fischer, Stuttgart 1982; 207–208
- Keller F, Mohlzahn M, Vohringer HF. Pharmakotherapie bei Niereninsuffizienz. Inn Med 1982; 9: 377–381
- Dettli L, Galeazzi RL. Pharmakokinetische Grundlagen der Arz-neimittelforschung. Arzneimittelkompendium der Schweiz 1986; 2: 2051–2074
- Lee C C, Marbury TC. Drug therapy in patients undergoing hemodialysis: clinical pharmacokinetic considerations. Clin Pharmacokinet 1984; 9: 42–66
- Stevens EL. Gauging the severity of surgical sepsis. Arch Surg 1983; 118: 1190–1192
- Burton M E, Vasko M R, Brater DC. Comparison of drug dosing methods. Clin Pharmacokinet 1985; 10: 1–37
- Stoeckel K, McNamara P J, Brandt R, Plozza-Nottebrock H, Ziegler WH. Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics. Clin Pharmacol Ther 1981; 29: 650–657
- De'Clari F. Ceftriaxone pharmacokinetics during continuous arteriovenous hemofiltration. J Antimicrob Chemother 1991; 27: 394–396